Prognostic significance of erythropoietin and erythropoietin receptor in tongue squamous cell carcinoma

British Journal of Oral and Maxillofacial Surgery

Volumn 47, Issue 6, 2009, Pages 470-475

  Li, Hai Gang ^a   Li, Jin Song ^a   Chen, Wei Liang ^a   Wang, Lin ^a   Wu, Dong Hui ^a   Lin, Zhao Yu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Erythropoietin; Erythropoietin receptor; Immunohistochemistry; Prognosis; Survival; Tongue squamous cell carcinoma

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE COURSE; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; POSTOPERATIVE PERIOD; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; TONGUE CARCINOMA; TONGUE SQUAMOUS CELL CARCINOMA;

ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; ERYTHROPOIETIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ERYTHROPOIETIN; TONGUE NEOPLASMS;

EID: 68349128644     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2009.06.001     Document Type: Article

References (16)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics 2007. CA Cancer J Clin 57 (2007) 43-66
2. Sessions D.G., Spector G.J., Lenox J., Haughey B., Chao C., and Marks J. Analysis of treatment results for oral tongue cancer. Laryngoscope 112 (2002) 616-625
3. Lacombe C., and Mateux P. Biology of erythropoietin. Haematologica 83 (1998) 724-732
4. Ribatti D., Vacca A., Roccaro A.M., Crivellato E., and Presta M. Erythropoietin as an angiogenic factor. Eur J Clin Invest 33 (2003) 891-896
5. Ashley R.A., Dubuque S.H., Dvorak B., Woodward S.S., Williams S.K., and Kling P.J. Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr Res 51 (2002) 472-478
6. Sekiguchi N., Inoguchi T., Kobayashi K., and Nawata H. Effect of erythropoietin on endothelial cell apoptosis induced by high glucose. Diabetes Res Clin Pract 66 Suppl. 1 (2004) 103-107
7. Lai S.Y., Childs E.E., Xi S., et al. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene 24 (2005) 4442-4449 [Erratum in Oncogene 2005; 24:8126]
8. Mohyeldin A., Lu H., Dalgard C., et al. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. Neoplasia 7 (2005) 537-543
9. Horak E.R., Leek R., Klenk N., et al. Angiogenesis assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340 (1992) 1120-1124
10. Lee W.Y., Huang S.C., Hsu K.F., Tzeng C.C., and Shen W.L. Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence. Gynecol Oncol 108 (2008) 377-384
11. Batra S., Perelman N., Luck L.R., Shimada H., and Malik P. Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab Invest 83 (2003) 1477-1487
12. Acs G., Zhang P.J., Rebbeck T.R., Acs P., and Verma A. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer 95 (2002) 969-981
13. Westenfelder C., and Baranowski R.L. Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int 58 (2000) 647-657
14. Acs G., Zhang P.J., McGrath C.M., et al. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol 162 (2003) 1789-1806
15. Nakamatsu K., Nishimura Y., Suzuki M., Kanamori S., Maenishi G., and Yasuda Y. Erythropoietin/erythropoietin-receptor system as an angiogenic factor in chemically induced hepatic tumors. Int J Clin Oncol 9 (2004) 184-188
16. Roh J.L., Cho K.J., Kwon G.Y., et al. The prognostic value of hypoxia markers in T2-staged oral tongue cancer. Oral Oncol 45 (2009) 63-68